Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells

Lee,Jun Hee; Jung,Ho Kyung; Han,Yong‑Seok; Yoon,Yeo Min; Yun,Chul Won; Sun,Hwa Yeon; Cho,Hyun Woo; Lee,Sang Hun

doi:10.3892/mmr.2016.5706

Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells

Authors:
- Jun Hee Lee
- Ho Kyung Jung
- Yong‑Seok Han
- Yeo Min Yoon
- Chul Won Yun
- Hwa Yeon Sun
- Hyun Woo Cho
- Sang Hun Lee
View Affiliations

Affiliations: Department of Physiology, Laboratory for Vascular Medicine and Stem Cell Biology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan, South Gyeongsang 50612, Republic of Korea, Department of Herb Research, Jeollanamdo Development Institute of Traditional Korean Medicine, Jangheung, South Jeolla 59338, Republic of Korea, Department of Biochemistry, Medical Science Research Institute, Soonchunhyang University College of Medicine, Cheonan, South Chungcheong 31151, Republic of Korea, Department of Urology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul 04401, Republic of Korea, Department of Neurology, Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Published online on: September 5, 2016 https://doi.org/10.3892/mmr.2016.5706
Pages: 3777-3784
Copyright: © Lee et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human mesenchymal stem cells (MSCs) may be used in cell-based therapy to promote neovascularization for the treatment of ischemic diseases. However, high levels of reactive oxygen species (ROS) derived from the pathophysiological ischemic environment induce senescence and apoptosis of MSCs, resulting in reduced functionality and defective neovascularization. Therefore, the present study aimed to determine the protective effects of Cirsium setidens, a natural product, on oxidative stress‑induced apoptosis in MSCs. The present study investigated for the change of ROS levels in MSCs using ROS assays. In addition, cell viability determined by MTT and TUNEL assays. Western blot analysis was performed to investigate the change of apoptosis‑associated proteins in MSCs. Treatment of MSCs with hydrogen peroxide (H2O2; 200 µM) significantly increased intracellular ROS levels and cell death; however, pretreatment with C. setidens (100 µg/ml) suppressed H2O2‑induced ROS generation and increased the survival of MSCs. H2O2‑induced ROS production increased the levels of phosphorylated‑p38 mitogen activated protein kinase, c‑Jun N‑terminal kinase, ataxia telangiectasia mutated and p53; these increases were inhibited by pretreatment with C. setidens. In addition, C. setidens inhibited ROS‑induced apoptosis of MSCs by increasing the expression levels of the anti‑apoptotic protein B‑cell lymphoma 2 (BCL‑2), and decreasing the expression levels of the proapoptotic protein BCL‑2‑associated X protein. These findings indicated that pretreatment of MSCs with C. setidens may prevent ROS‑induced oxidative injury by regulating the oxidative stress‑associated signaling pathway, and suppressing the apoptosis‑associated signal pathway. Therefore, C. setidens may be developed as a beneficial broad‑spectrum agent for enhancing the effectiveness of MSC transplantation in the treatment of ischemic diseases.

View Figures

View References

1	Chamberlain G, Fox J, Ashton B and Middleton J: Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 25:2739–2749. 2007. View Article : Google Scholar : PubMed/NCBI
2	Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE and Elliott JA: Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology. 71:181–197. 2015. View Article : Google Scholar : PubMed/NCBI
3	Amiri F, Jahanian-Najafabadi A and Roudkenar MH: In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments: In vitro augmentation of mesenchymal stem cells viability. Cell Stress Chaperones. 20:237–251. 2015. View Article : Google Scholar :
4	Wei H, Li Z, Hu S, Chen X and Cong X: Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK. J Cell Biochem. 111:967–978. 2010. View Article : Google Scholar : PubMed/NCBI
5	Li Q, Wang Y and Deng Z: Pre-conditioned mesenchymal stem cells: A better way for cell-based therapy. Stem Cell Res Ther. 4:632013. View Article : Google Scholar : PubMed/NCBI
6	Lee KA, Shim W, Paik MJ, Lee SC, Shin JY, Ahn YH, Park K, Kim JH, Choi S and Lee G: Analysis of changes in the viability and gene expression profiles of human mesenchymal stromal cells over time. Cytotherapy. 11:688–697. 2009. View Article : Google Scholar : PubMed/NCBI
7	Xu J, Qian J, Xie X, Lin L, Zou Y, Fu M, Huang Z, Zhang G, Su Y and Ge J: High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int J Mol Sci. 13:17104–17120. 2012. View Article : Google Scholar
8	Jeong DM, Jung HA and Choi JS: Comparative antioxidant activity and HPLC profiles of some selected Korean thistles. Arch Pharm Res. 31:28–33. 2008. View Article : Google Scholar : PubMed/NCBI
9	Yoo YM, Nam JH, Kim MY, Choi J and Park HJ: Pectolinarin and pectolinarigenin of Cirsium setidens prevent the hepatic injury in rats caused by d-galactosamine via an antioxidant mechanism. Biol Pharm Bull. 31:760–764. 2008. View Article : Google Scholar : PubMed/NCBI
10	Noh H, Lee H, Kim E, Mu L, Rhee YK, Cho CW and Chung J: Inhibitory effect of a Cirsium setidens extract on hepatic fat accumulation in mice fed a high-fat diet via the induction of fatty acid β-oxidation. Biosci Biotechnol Biochem. 77:1424–1429. 2013. View Article : Google Scholar
11	Thao NT, Cuong TD, Hung TM, Lee JH, Na M, Son JK, Jung HJ, Fang Z, Woo MH, Choi JS and Min BS: Simultaneous determination of bioactive flavonoids in some selected Korean thistles by high-performance liquid chromatography. Arch Pharm Res. 34:455–461. 2011. View Article : Google Scholar : PubMed/NCBI
12	Russo V, Young S, Hamilton A, Amsden BG and Flynn LE: Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury. Biomaterials. 35:3956–3974. 2014. View Article : Google Scholar : PubMed/NCBI
13	Gimble JM, Katz AJ and Bunnell BA: Adipose-derived stem cells for regenerative medicine. Circ Res. 100:1249–1260. 2007. View Article : Google Scholar : PubMed/NCBI
14	Lee WB, Kwon HC, Cho OR, Lee KC, Choi SU, Baek NI and Lee KR: Phytochemical constituents of Cirsium setidens Nakai and their cytotoxicity against human cancer cell lines. Arch Pharm Res. 25:628–635. 2002. View Article : Google Scholar : PubMed/NCBI
15	Lee SH, Heo SI, Li L, Lee MJ and Wang MH: Antioxidant and hepatoprotective activities of Cirsium setidens Nakai against CCl4-induced liver damage. Am J Chin Med. 36:107–114. 2008. View Article : Google Scholar : PubMed/NCBI
16	Ahn MJ, Hur SJ, Kim EH, Lee SH, Shin JS, Kim MK, Uchizono JA, Whang WK and Kim DS: Scopoletin from Cirsium setidens increases melanin synthesis via CREB phosphorylation in B16F10 cells. Korean J Physiol Pharmacol. 18:307–311. 2014. View Article : Google Scholar : PubMed/NCBI
17	Lim H, Son KH, Chang HW, Bae K, Kang SS and Kim HP: Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from Cirsium chanroenicum. Biol Pharm Bull. 31:2063–2067. 2008. View Article : Google Scholar : PubMed/NCBI
18	Matsuzawa A and Ichijo H: Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta. 1780:1325–1336. 2008. View Article : Google Scholar : PubMed/NCBI
19	Cuevas BD, Abell AN and Johnson GL: Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene. 26:3159–3171. 2007. View Article : Google Scholar : PubMed/NCBI
20	Chung YM, Park SH, Tsai WB, Wang SY, Ikeda MA, Berek JS, Chen DJ and Hu MC: FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. Nat Commun. 3:10002012. View Article : Google Scholar : PubMed/NCBI
21	Lavin MF, Gueven N, Bottle S and Gatti RA: Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br Med Bull. 81–82:129–147. 2007. View Article : Google Scholar
22	Guo Z, Kozlov S, Lavin MF, Person MD and Paull TT: ATM activation by oxidative stress. Science. 330:517–521. 2010. View Article : Google Scholar : PubMed/NCBI
23	Chen BP, Li M and Asaithamby A: New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress. Cancer Lett. 327:103–110. 2012. View Article : Google Scholar
24	Mollazadeh S, Fazly Bazzaz BS and Kerachian MA: Role of apoptosis in pathogenesis and treatment of bone-related diseases. J Orthop Surg Res. 10:152015. View Article : Google Scholar : PubMed/NCBI
25	Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
26	Virag L, Robaszkiewicz A, Rodriguez-Vargas JM and Oliver FJ: Poly(ADP-ribose) signaling in cell death. Mol Aspects Med. 34:1153–1167. 2013. View Article : Google Scholar : PubMed/NCBI